Larimar Therapeutics LRMR
NASDAQ LRMR
$3.06 -0.13 (-4.23%)
At close: Oct 1, 2026 · 4:00 PM EDT

Larimar Therapeutics (LRMR) Depreciation & Amortization (CF) (2013 - 2025)

Updated

Larimar Therapeutics (LRMR) reported Depreciation & Amortization (CF) of $87,000 for Q4 2025, up 13.0% from $77,000 a year earlier but down 1.1% from the prior quarter.

Analysis

Larimar Therapeutics (LRMR) Depreciation & Amortization (CF) (2013 - 2025) Analysis & Trends

For FY2025, Larimar Therapeutics posted Depreciation & Amortization (CF) of $350,000, up 10.1% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 17.7% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $318,000 in FY2024 (+2.3%), $311,000 in FY2023 (-2.2%), $318,000 in FY2022 (-2.5%) and $326,000 in FY2021 (+110.3%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $50,000 in Q2 2021 and a high of $100,000 in Q3 2021.
  • Year over year, Depreciation & Amortization (CF) gained in five of the last eight quarters, with growth averaging 6.4%.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2021 (growth of 334.8%); the low point was Q3 2022 (a decline of 23.0%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $88,000 (Q3 2025), $87,000 (Q2 2025) and $88,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Larimar Therapeutics 331.39 Mn -275.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 87,000.00
Sep 30, 2025 88,000.00
Jun 30, 2025 87,000.00
Mar 31, 2025 88,000.00
Dec 31, 2024 77,000.00
Sep 30, 2024 74,000.00
Jun 30, 2024 87,000.00
Mar 31, 2024 80,000.00
Dec 31, 2023 81,000.00
Sep 30, 2023 76,000.00
Jun 30, 2023 76,000.00
Mar 31, 2023 78,000.00
Dec 31, 2022 78,000.00
Sep 30, 2022 77,000.00
Jun 30, 2022 81,000.00
Mar 31, 2022 82,000.00
Dec 31, 2021 88,000.00
Sep 30, 2021 100,000.00
Jun 30, 2021 50,000.00
Mar 31, 2021 100,000.00
API Access

Larimar Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=LRMR&period=max&api_key=YOUR_API_KEY